RIMON THERAPEUTICS

Rimon Therapeutics develops Theramers, a therapeutic polymer to treat chronic wounds. The company is based in Mississauga, Ontario.

#SimilarOrganizations #People #Website #More

RIMON THERAPEUTICS

Industry:
Biotechnology Medical Therapeutics

Founded:
2000-01-01

Address:
Mississauga, Ontario, Canada

Country:
Canada

Website Url:
http://www.rimontherapeutics.com

Total Employee:
1+

Status:
Active

Contact:
6472580408

Technology used in webpage:
SPF Namecheap DNS WordPress Hosting Namecheap Hosting Namecheap


Similar Organizations

palisade-therapeutics-logo

Palisade Therapeutics

Palisade Therapeutics develops therapeutics-based products for the treatment of neurological diseases.

Founder


michael-may_image

Michael May

Official Site Inspections

http://www.rimontherapeutics.com

Unable to get host informations!!!

Loading ...

More informations about "Rimon Therapeutics"

Rimon Therapeutics - Crunchbase Company Profile & Funding

Rimon Therapeutics develops Theramers, a therapeutic polymer to treat chronic wounds. The company is based in Mississauga, Ontario.See details»

Rimon Therapeutics Ltd Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Rimon Therapeutics Ltd of Mississauga, ON. Get the latest business insights from Dun & Bradstreet.See details»

Rimon Therapeutics Ltd. - Drug pipelines, Patents, Clinical trials ...

Explore Rimon Therapeutics Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»

Rimon Therapeutics - Overview, News & Similar companies

Rimon Therapeutics is an emerging life sciences company developing unique therapeutics for large indications based on its proprietary Theramerยฎ pla tform. Theramers are medical โ€ฆSee details»

Firm Earns Honor for Developing Bioactive Polymers - MDDI Online

Sep 1, 2006ย ยท Rimon Therapeutics Ltd. (Toronto) has developed what it calls Theramers: medical polymers that have biological activity in and of themselves, without use of drugs. In essence, โ€ฆSee details»

RIMON THERAPEUTICS LTD. :: Ontario (Canada) - OpenCorporates

Free and open company data on Ontario (Canada) company RIMON THERAPEUTICS LTD. (company number 1230777), Toronto, OntarioSee details»

Rimon Therapeutics Ltd. - LinkedIn

Sign in to see who you already know at Rimon Therapeutics Ltd. Sign in Welcome backSee details»

Rimo Therapeutics - Overview, News & Competitors - ZoomInfo

Rimo Therapeutics LLC is a company that operates in the Biotechnology industry. It employs 6-10 people and has $0M-$1M of revenue. Read More. View Company Info for Free. Is this data โ€ฆSee details»

Rimon Therapeutics - Company Profile - Tracxn

Oct 19, 2024ย ยท Private label brand offering medical polymers. The products developed by the company include Theramers (therapeutic polymers, that have drug-like activity, to treat chronic โ€ฆSee details»

Rimon Therapeutics Ltd. - Medtech Insight

Mar 1, 2004ย ยท The company has initially focused its product development efforts on wound healing, with two technologies, polymer beads that induce angiogenesis, and a polymer that โ€ฆSee details»

Michael May - President & CEO @ CCRM - Crunchbase

Michael is currently the Chief Executive Officer of CCRM. Prior to CCRM, Michael was the President, Chief Operating Officer and co-founder of Rimon. Therapeutics Ltd., a Toronto โ€ฆSee details»

Rimon Therapeutics - Tech Stack, Apps, Patents & Trademarks

Rimon Therapeutics develops Theramers, a therapeutic polymer to treat chronic wounds.See details»

Sefton, Michael Vivian - Engineering Alumni & Friends

Co-founder of Rimon Therapeutics to bring new biomaterials to benefit patients. Canadian Society for Chemical Engineering Albright and Wilson Americaโ€™s Ward, (1989); Century of โ€ฆSee details»

Michael May - CCRM

Michael May is President and CEO of the Centre for Commercialization of Regenerative Medicine (CCRM), a Canadian, not-for-profit that develops technologies, launches new companies and โ€ฆSee details»

Rimon Therapeutics - Products, Competitors, Financials, โ€ฆ

Rimon Therapeutics, through the application of its polymer chemistry platform, is developing therapeutics to address unmet needs in important disease indicators with large markets. Use โ€ฆSee details»

Michael May: Positions, Relations and Network - MarketScreener

Sep 23, 2008ย ยท May founded Rimon Therapeutics Ltd., where he worked as Chief Operating Officer from 2006 to 2010.See details»

Michael H. May PhD - bioforumconf.com

Apr 6, 2016ย ยท Prior to CCRM, Michael was the President, and co-founder, of Rimon Therapeutics Ltd., a Toronto-based regenerative medicine company developing novel medical polymers that โ€ฆSee details»

Rimon Therapeutics - CB Insights

Explore {Rimon Therapeutics's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»

Eikon Therapeutics

Nov 20, 2024ย ยท At Eikon, we discover and develop new medicines by reimagining what is possible โ€” inventing new technologies to bring to light quantitative information about the behavior of โ€ฆSee details»

Mission Therapeutics โ€“ Deubiquitylating enzymes: multiple drug ...

World-leading DUB platform translating scientific advances into transformative therapies. First-in-class small molecule DUB inhibitors developed in-house and with partners. Multiple in-house โ€ฆSee details»

linkstock.net © 2022. All rights reserved